Precision Tolerogens are the answer to the industry need for agents to shut off the patient’s rejection to MAb therapeutics. PT™ drive innate immunity into an inhibitory cascade working from suppressive Antigen Presenting Cells. Drug development with Precision Tolorogens can strongly impact therapies of RA and autoimmunity.